NEW YORK (GenomeWeb News) – After matching a 52-week high of $23 on Monday before pulling back to close at $22.33 on the Nasdaq, up 6.4 percent for the day, shares of Sequenom hit a new 52-week high on Tuesday morning of $24.50.
 
The San Diego-based firm’s stock bucked the trend on a dismal Monday for the stock market, which saw the Dow Jones Industrial Average lose 241.81, or 2.1 percent, while the Nasdaq dropped 2 percent. The $23 per share price matched the firm’s 52-week high reached on July 16.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.